Skip to content

Clinical trials

Completed Phase 3 Heartburn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heartburn Phase: Phase 3 Status: Completed Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20055
20065
20081
20092
20102
20112
20131
20161
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda5
Novartis4
AstraZeneca3
Eisai Inc.2
Abbott1
Ahn-Gook Pharmaceuticals Co.,Ltd1
Braintree Laboratories1
Chang Gung Memorial Hospital1
Forest Laboratories1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heartburn24
Gastroesophageal Reflux14
Dyspepsia3
Abdominal Pain1
Anorexia1
Laryngopharyngeal Reflux1
Nausea1
Non-Erosive Reflux Disease1
Parasomnias1
Vomiting1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.